Drugs / recombinant human alpha B-crystallin
recombinant human alpha B-crystallin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02442557 Comparator | Dec 2009 → Oct 2010 | multiple sclerosis | Delta Crystallon BV | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant human alpha B-crystallin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02442557 ↗ |
| Modality | Protein / enzyme biologic | “the small heat shock protein alpha B-crystallin (HspB5)” PMID 26599332 ↗ Nov 2015 |
| Route | Intravenous | “intravenous injection” NCT02442557 ↗ |